Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study Phase II

Research Institute for Endocrine Sciences (Iran)0 sites15,005 target enrollmentNovember 27, 2008

Overview

2000 rationale and design in Azizi F, Rahmani M, Emami, H, Majid M. Tehran lipid and glucose study (TLGS): rationale and design. CVD Prevention 2000; 3:50-3. 2. 2002 results in http://www.ncbi.nlm.nih.gov/pubmed/12643001 3. 2007 results in http://www.ncbi.nlm.nih.gov/pubmed/17999777 4. 2008 nutritional intervention results in http://www.ncbi.nlm.nih.gov/pubmed/18349527 5. 2008 anthropometric parameter results in http://www.ncbi.nlm.nih.gov/pubmed/18772585 6. 2008 nested case control study results in http://www.ncbi.nlm.nih.gov/pubmed/18533046 7. 2008 assessment of alternative definitions results in http://www.ncbi.nlm.nih.gov/pubmed/18282630 8. 2008 prospective study results in http://www.ncbi.nlm.nih.gov/pubmed/18068961 9. 2009 phase II protocol in http://www.ncbi.nlm.nih.gov/pubmed/19166627 10. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20494239 11. 2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/28795355

Registry

who.int

Start Date

November 27, 2008

End Date

March 1, 2020

Last Updated

7 years ago

Study Type

Interventional

Sex

All

Sponsor

Research Institute for Endocrine Sciences (Iran)

•1\. Individuals aged 3 years and over, either sex
•2\. Residents of the District 13 of Tehran
•3\. Under the coverage of three medical health centres, selected using multistage cluster random sampling method
•4\. Agree for all members of each family, including those not having risk factors, to be enrolled